JPMorgan Cuts PT on Centene Corporation (CNC) to $41 From $45 – Here’s Why

Centene Corporation (NYSE:CNC) is one of the best affordable stocks to buy with good earnings growth. JPMorgan cut the price target on Centene Corporation (NYSE:CNC) to $41 from $45 on March 19, reiterating a Neutral rating on the shares. The firm considers the stock’s 16% selloff in the past week as a reminder that Managed Medicaid “remains the subsection of managed care (and perhaps healthcare services) with the widest error bars in 2026.” JPMorgan cut the stock’s estimates to take into account near-term uncertainty and assumed a 2027 Affordable Care Act exchange enrollment contraction.

In another development, Mizuho cut the price target on Centene Corporation (NYSE:CNC) to $41 from $47 on March 11, maintaining a Neutral rating on the shares and updating the company’s model after its fiscal Q4 report. The firm told investors in a research note that Centene Corporation’s (NYSE:CNC) shares were down 14% following the company’s comments at a competitor’s conference. Mizuho cited a more conservative valuation multiple pending greater clarity on the potential risk shifts if health insurance exchange dis-enrollment is worse than expectations for the target cut.

Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides programs and services to government-sponsored healthcare programs. The company’s operations are divided into the following segments: Medicaid, Medicare, Commercial, and Other.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.